Wong S K, Koch D D, Emery J M
J Cataract Refract Surg. 1987 Jan;13(1):17-20. doi: 10.1016/s0886-3350(87)80003-2.
We conducted a retrospective study of our first 75 consecutive patients receiving secondary intraocular lens implants. Ninety-seven percent had postoperative visual acuities of greater than or equal to 20/40; 86%, greater than or equal to 20/25. Four percent of patients lost two or more lines of vision. Complications included retinal detachment (4%), transient cystoid macular edema (3%), transient corneal edema (3%), pupillary block glaucoma (1%), and progression of an epiretinal membrane (1%). Patients requiring anterior vitrectomy had the least favorable outcome, with a 28% incidence of retinal complications. Overall, these data show secondary intraocular lens implantations to be safe and effective. However, greater caution is recommended for patients who will require anterior vitrectomy because of the higher rate of retinal complications.
我们对首批连续接受二期人工晶状体植入的75例患者进行了一项回顾性研究。97%的患者术后视力大于或等于20/40；86%的患者视力大于或等于20/25。4%的患者视力下降两行或更多。并发症包括视网膜脱离（4%）、短暂性黄斑囊样水肿（3%）、短暂性角膜水肿（3%）、瞳孔阻滞性青光眼（1%）和视网膜前膜进展（1%）。需要进行前部玻璃体切除术的患者预后最差，视网膜并发症发生率为28%。总体而言，这些数据表明二期人工晶状体植入是安全有效的。然而，对于因视网膜并发症发生率较高而需要进行前部玻璃体切除术的患者，建议更加谨慎。
